29 results
424B5
VERV
Verve Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
4:47pm
and interest rates, on our business, operations, strategy and goals.
We may not actually achieve the plans, intentions or expectations disclosed
424B5
babwcr dguvz34q
28 Nov 23
Prospectus supplement for primary offering
4:25pm
DEF 14A
gqnmjafs0s 2gxkp
29 Apr 22
Definitive proxy
7:01am
10-K
1rmezx4cftuyufy3gdp
14 Mar 22
Annual report
7:04am
8-K
EX-99.1
8n5bi0hp0k0ib0 zf6
14 Mar 22
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results
6:49am
10-Q
e9mvfy7oke4f4eka
12 Aug 21
Quarterly report
8:53am
424B4
9rk4hnmvt4l 36
17 Jun 21
Prospectus supplement with pricing info
4:50pm